Reply to K. Orendi et al-Reference-Cited by-同舟云学术

Reply to K. Orendi et al

Published:2013-06-20 Issue:18 Volume:31 Page:2361-2362
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Mrózek Krzysztof¹,Nicolet Deedra²,Maharry Kati S.²,Carroll Andrew J.³,Marcucci Guido¹,Bloomfield Clara D.¹

Affiliation:

1. The Ohio State University Comprehensive Cancer Center, Columbus, OH

2. The Ohio State University Comprehensive Cancer Center, Columbus, OH; and Alliance for Clinical Trials in Oncology Statistics and Data Center, Mayo Clinic, Rochester, MN

3. University of Alabama at Birmingham, Birmingham, AL

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2013.49.2504

Reference8 articles.

1. Molecular Cytogenetics and Multiplex Reverse-Transcriptase Polymerase Chain Reaction for Risk Stratification in Acute Myeloid Leukemia

2. Prognostic Significance of the European LeukemiaNet Standardized System for Reporting Cytogenetic and Molecular Alterations in Adults With Acute Myeloid Leukemia

3. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

4. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcome prediction by the 2022 European LeukemiaNet genetic-risk classification for adults with acute myeloid leukemia: an Alliance study;Leukemia;2023-02-23